Quantitative Evaluation of the Use of Actigraphy for Neurological and Psychiatric Disorders | Zendy

Weidong Pan | Zendy; Yu Song | Zendy; Shin Kwak | Zendy; Sohei Yoshida | Zendy; Yoshiharu Yamamoto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Quantitative Evaluation of the Use of Actigraphy for Neurological and Psychiatric Disorders

Author(s) -

Weidong Pan,

Yu Song,

Shin Kwak,

Sohei Yoshida,

Yoshiharu Yamamoto

Publication year - 2014

Publication title -

behavioural neurology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.859

H-Index - 48

eISSN - 1875-8584

pISSN - 0953-4180

DOI - 10.1155/2014/897282

Subject(s) - actigraphy , dementia , depression (economics) , movement disorders , physical medicine and rehabilitation , psychiatry , disease , medicine , stroke (engine) , psychology , insomnia , mechanical engineering , engineering , economics , macroeconomics

Quantitative and objective evaluation of disease severity and/or drug effect is necessary in clinical practice. Wearable accelerometers such as an actigraph enable long-term recording of a patient's movement during activities and they can be used for quantitative assessment of symptoms due to various diseases. We reviewed some applications of actigraphy with analytical methods that are sufficiently sensitive and reliable to determine the severity of diseases and disorders such as motor and nonmotor disorders like Parkinson's disease, sleep disorders, depression, behavioral and psychological symptoms of dementia (BPSD) for vascular dementia (VD), seasonal affective disorder (SAD), and stroke, as well as the effects of drugs used to treat them. We believe it is possible to develop analytical methods to assess more neurological or psychopathic disorders using actigraphy records.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research